carteolol has been researched along with Hypertension in 30 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of 6 weeks of treatment with dilevalol 100 mg once daily, or carteolol 10 mg once daily, on renal blood flow (RBF), glomerular filtration rate (GFR) and total renal vascular resistance (TRR) were studied in 10 patients with mild-to-moderate essential hypertension in a randomised cross-over experiment." | 9.06 | Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension. ( Baba, T; Murabayashi, S; Takebe, K; Tomiyama, T, 1990) |
| " We have studied the ability of carteolol, a nonselective beta-adrenoceptor antagonist with intrinsic sympathomimetic activity, to produce such remissions of hypertension." | 9.06 | Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity. ( Brachfeld, J; Burris, JF; Giles, TD; Mersch, DP; Moyer, RR; Mroczek, WJ; Roffidal, L; Sander, GE; Thomas, MG, 1988) |
| "Publications dealing with investigations made with 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) on patients with essential hypertension, are briefly reviewed." | 9.05 | [Clinical experiences with carteolol in patients with essential hypertension]. ( Viehmann, P, 1983) |
| "Captopril is an orally active angiotensin-converting enzyme inhibitor that has been widely used in treating hypertension." | 7.67 | Cough associated with the use of captopril. ( Kaneko, Y; Sesoko, S, 1985) |
| "The ability of 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) to lower the blood pressure was tested in an open clinical study on 66 patients with I-III degree essential hypertension." | 7.66 | [Hypotensive effect of carteolol in patients with essential hypertension]. ( Beythien, RD, 1983) |
| "The effect of short- and long-term administration of carteolol on renal function has been examined in healthy subjects and in hypertensive patients with or without renal failure." | 5.28 | Effect of carteolol on renal function in healthy subjects and patients with hypertension. ( Asano, Y; Furuya, H; Hosoda, S; Tabei, K, 1989) |
| "Carteolol was shown to be safe and well tolerated by most patients." | 5.27 | Carteolol treatment of essential hypertension: a long-term study of safety and efficacy. ( Klepper, MJ; Luther, RR; Maurath, CJ; Peckinpaugh, RO; Ringham, GL, 1986) |
| " To investigate these aspects, we assessed the cardiovascular responsiveness to norepinephrine and angiotensin II, plasma levels of catecholamines, angiotensin II, ANF and aldosterone and the body sodium-blood volume state of 15 patients with essential hypertension (mean age +/- s." | 5.07 | Modulation of noradrenergic but not angiotensinergic blood pressure control by beta-blockade with carteolol. ( Ferrier, C; Morger, D; Saxenhofer, H; Shaw, SG; Weidmann, P, 1991) |
| "The effects of 6 weeks of treatment with dilevalol 100 mg once daily, or carteolol 10 mg once daily, on renal blood flow (RBF), glomerular filtration rate (GFR) and total renal vascular resistance (TRR) were studied in 10 patients with mild-to-moderate essential hypertension in a randomised cross-over experiment." | 5.06 | Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension. ( Baba, T; Murabayashi, S; Takebe, K; Tomiyama, T, 1990) |
| " We have studied the ability of carteolol, a nonselective beta-adrenoceptor antagonist with intrinsic sympathomimetic activity, to produce such remissions of hypertension." | 5.06 | Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity. ( Brachfeld, J; Burris, JF; Giles, TD; Mersch, DP; Moyer, RR; Mroczek, WJ; Roffidal, L; Sander, GE; Thomas, MG, 1988) |
| "Publications dealing with investigations made with 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) on patients with essential hypertension, are briefly reviewed." | 5.05 | [Clinical experiences with carteolol in patients with essential hypertension]. ( Viehmann, P, 1983) |
| "Penbutolol and carteolol are two new long acting, nonselective beta-adrenergic blockers which have been approved for the treatment of systemic hypertension." | 4.78 | Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism. ( Covey, S; Frishman, WH, 1990) |
| "Captopril is an orally active angiotensin-converting enzyme inhibitor that has been widely used in treating hypertension." | 3.67 | Cough associated with the use of captopril. ( Kaneko, Y; Sesoko, S, 1985) |
| "The symptom limited maximal exercise was performed by a supine bicycle ergometer before and 12 weeks after oral carteolol therapy in 10 patients with essential hypertension of WHO Stage 1 and 2." | 3.67 | Effects of long use of a beta-blocker, carteolol, on exercise hemodynamics in hypertensives. ( Katori, R; Morii, S; Morishita, M; Ohno, M; Oogai, T; Tashi, M, 1985) |
| "The ability of 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) to lower the blood pressure was tested in an open clinical study on 66 patients with I-III degree essential hypertension." | 3.66 | [Hypotensive effect of carteolol in patients with essential hypertension]. ( Beythien, RD, 1983) |
| "We studied the effects of chronic administration of beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity (ISA): carteolol (with ISA) and propranolol (without ISA), respectively, on the heart of spontaneously hypertensive rat (SHR) and Wistar Kyoto rat (WKY)." | 1.28 | Effects of chronic administration of carteolol on beta-adrenoceptors in spontaneously hypertensive rat heart. ( Ebii, K; Fujiwara, M; Fukunaga, R; Kimura, Y; Nakayama, S; Saitoh, Y; Taniguchi, T, 1991) |
| "The effect of short- and long-term administration of carteolol on renal function has been examined in healthy subjects and in hypertensive patients with or without renal failure." | 1.28 | Effect of carteolol on renal function in healthy subjects and patients with hypertension. ( Asano, Y; Furuya, H; Hosoda, S; Tabei, K, 1989) |
| "Carteolol is an effective antihypertensive." | 1.27 | Time-dependent antihypertensive effect of carteolol--a beta-adrenoceptor antagonist with partial agonist activity. ( Giles, TD; Kaneish, A; Quiroz, AC; Sander, GE, 1984) |
| "Carteolol was shown to be safe and well tolerated by most patients." | 1.27 | Carteolol treatment of essential hypertension: a long-term study of safety and efficacy. ( Klepper, MJ; Luther, RR; Maurath, CJ; Peckinpaugh, RO; Ringham, GL, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (70.00) | 18.7374 |
| 1990's | 9 (30.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tarkiainen, A | 1 |
| Saraste, K | 1 |
| Seppälä, T | 1 |
| Gordin, A | 1 |
| Auvinen, J | 1 |
| Tsukiyama, H | 1 |
| Otsuka, K | 1 |
| Horii, M | 1 |
| Yoshii, Y | 1 |
| Hatori, Y | 1 |
| Nakamura, Y | 1 |
| Nemoto, E | 1 |
| Yamato, T | 1 |
| Sakai, T | 1 |
| Yamamoto, Y | 1 |
| Viehmann, P | 1 |
| Lorenz, D | 1 |
| Beythien, RD | 1 |
| Werning, C | 1 |
| Rosprich, G | 1 |
| Sölter, H | 1 |
| Giles, TD | 3 |
| Sander, GE | 3 |
| Kaneish, A | 1 |
| Quiroz, AC | 1 |
| Sasaki, H | 1 |
| Naka, K | 1 |
| Kishi, Y | 1 |
| Ohoshi, T | 1 |
| Hagihara, T | 1 |
| Matsuo, H | 1 |
| Sowa, R | 1 |
| Matsumoto, G | 1 |
| Sanke, T | 1 |
| Nanjo, K | 1 |
| Baba, T | 2 |
| Takebe, K | 2 |
| Tomiyama, T | 2 |
| Ebii, K | 1 |
| Fukunaga, R | 1 |
| Taniguchi, T | 1 |
| Fujiwara, M | 1 |
| Nakayama, S | 1 |
| Saitoh, Y | 1 |
| Kimura, Y | 1 |
| Saxenhofer, H | 1 |
| Morger, D | 1 |
| Weidmann, P | 1 |
| Ferrier, C | 1 |
| Shaw, SG | 1 |
| Kohno, M | 1 |
| Yokokawa, K | 1 |
| Yasunari, K | 1 |
| Murakawa, K | 1 |
| Kurihara, N | 1 |
| Takeda, T | 1 |
| Hasui, K | 1 |
| Ohmoto, T | 1 |
| Tamaki, T | 1 |
| Fukui, K | 1 |
| Iwao, H | 1 |
| Abe, Y | 1 |
| Levenson, J | 2 |
| Devynck, MA | 1 |
| Pithois-Merli, I | 1 |
| Le Quan Sang, KH | 1 |
| Filitti, V | 2 |
| Simon, A | 2 |
| Murabayashi, S | 1 |
| Frishman, WH | 1 |
| Covey, S | 1 |
| Rosales, OR | 1 |
| Roffidal, L | 2 |
| Given, MB | 1 |
| Merli, IP | 1 |
| Misu, Y | 2 |
| Kuwahara, M | 2 |
| Kubo, T | 2 |
| Amano, H | 1 |
| Isohisa, I | 1 |
| Shima, K | 1 |
| Koyama, T | 1 |
| Yamashita, K | 1 |
| Namba, K | 1 |
| Hosaka, T | 1 |
| Maezawa, H | 1 |
| Tabei, K | 1 |
| Furuya, H | 1 |
| Asano, Y | 1 |
| Hosoda, S | 1 |
| Thomas, MG | 1 |
| Mersch, DP | 1 |
| Moyer, RR | 1 |
| Burris, JF | 1 |
| Mroczek, WJ | 1 |
| Brachfeld, J | 1 |
| Murai, A | 1 |
| Miyata, S | 1 |
| Miyahara, T | 1 |
| Sako, Y | 1 |
| Lohmöller, G | 1 |
| Conca, W | 1 |
| Pötzl, C | 1 |
| Luther, RR | 1 |
| Maurath, CJ | 1 |
| Klepper, MJ | 1 |
| Peckinpaugh, RO | 1 |
| Ringham, GL | 1 |
| Sesoko, S | 1 |
| Kaneko, Y | 1 |
| Katori, R | 1 |
| Tashi, M | 1 |
| Ohno, M | 1 |
| Oogai, T | 1 |
| Morishita, M | 1 |
| Morii, S | 1 |
1 review available for carteolol and Hypertension
| Article | Year |
|---|---|
Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism.
Topics: Arrhythmias, Cardiac; Carteolol; Chemical Phenomena; Chemistry; Coronary Disease; Humans; Hypertensi | 1990 |
11 trials available for carteolol and Hypertension
| Article | Year |
|---|---|
A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiloride; Antihypertensive Agents; Blood Pressure; Carteo | 1981 |
[Clinical experiences with carteolol in patients with essential hypertension].
Topics: Adult; Aged; Blood Pressure; Carteolol; Clinical Trials as Topic; Double-Blind Method; Female; Heart | 1983 |
[Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol].
Topics: Adult; Carteolol; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Propanolamines | 1983 |
Metabolic effects of carteolol and dilevalol in essential hypertension.
Topics: Carteolol; Humans; Hypertension; Labetalol | 1992 |
Modulation of noradrenergic but not angiotensinergic blood pressure control by beta-blockade with carteolol.
Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Carteolol; Female; Humans; Hyperte | 1991 |
Acute effects of alpha- and beta-adrenoceptor blockade on plasma atrial natriuretic peptides during exercise in elderly patients with mild hypertension.
Topics: Aged; Atenolol; Atrial Natriuretic Factor; Carteolol; Exercise; Female; Humans; Hypertension; Male; | 1991 |
Dynamic association between artery shear flow condition and platelet cytosolic free Ca2+ concentration in human hypertension.
Topics: Arteries; Atenolol; Blood Platelets; Calcium; Carteolol; Cytosol; Double-Blind Method; Female; Hemod | 1990 |
Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension.
Topics: Adult; Aldosterone; Blood Proteins; Carteolol; Female; Glomerular Filtration Rate; Hemodynamics; Hum | 1990 |
Carteolol and penbutolol for hypertension.
Topics: Adrenergic beta-Agonists; Carteolol; Clinical Trials as Topic; Humans; Hypertension; Penbutolol; Pro | 1989 |
Comparative long-term vasoactive effects of atenolol and carteolol on the properties of the small and large arteries of the upper extremities in human essential hypertension.
Topics: Adult; Arteries; Atenolol; Blood Flow Velocity; Blood Pressure; Brachial Artery; Carteolol; Double-B | 1989 |
Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity.
Topics: Blood Pressure; Carteolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertensi | 1988 |
18 other studies available for carteolol and Hypertension
| Article | Year |
|---|---|
Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Carteolol; Hemodynamics; Humans; Hypertension; Me | 1983 |
[Human pharmacology of carteolol].
Topics: Administration, Oral; Blood Platelets; Carteolol; Coronary Disease; Hemodynamics; Humans; Hypertensi | 1983 |
[Hypotensive effect of carteolol in patients with essential hypertension].
Topics: Adult; Aged; Blood Pressure; Carteolol; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; | 1983 |
[Treatment of essential hypertension with the beta-receptor antagonist carteolol. A multicenter study].
Topics: Adult; Aged; Blood Pressure; Carteolol; Electrocardiography; Female; Heart Rate; Humans; Hypertensio | 1983 |
Time-dependent antihypertensive effect of carteolol--a beta-adrenoceptor antagonist with partial agonist activity.
Topics: Adult; Aged; Blood Pressure; Carteolol; Dose-Response Relationship, Drug; Drug Evaluation; Heart Rat | 1984 |
Nicardipine may impair glucose metabolism in hypertensive diabetic patients.
Topics: Adult; Aged; Atenolol; Carteolol; Diabetes Mellitus, Type 2; Diltiazem; Enalapril; Female; Glucose; | 1994 |
Effects of chronic administration of carteolol on beta-adrenoceptors in spontaneously hypertensive rat heart.
Topics: Aging; Animals; Binding Sites; Blood Pressure; Carteolol; Dihydroalprenolol; Heart Rate; Hypertensio | 1991 |
Effects of prolonged treatment with beta-adrenoceptor antagonist, carteolol on systemic and regional hemodynamics in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Cardiac Output; Carteolol; Cerebrovascular Disorders; Hemodyna | 1991 |
Carteolol, an antihypertensive beta-blocker with intrinsic sympathomimetic activity, reduces ECG evidence of left ventricular hypertrophy.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Carteolol; Electrocardiography; Humans; | 1989 |
Some relevance of presynaptic beta-adrenoceptors to development of hypertension in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Carteolol; Feedback; Heart Rate; Hypertension; Male; Mesenteric Arteries; M | 1987 |
Adrenaline as an endogenous agonist for presynaptic beta-adrenoceptors and their relevance to the development of hypertension in spontaneously hypertensive rats.
Topics: Animals; Carteolol; Epinephrine; Guinea Pigs; Hypertension; Ligands; Male; Rats; Rats, Inbred SHR; R | 1988 |
[Increased creatine phosphokinase (CPK) level and muscle symptoms during beta-blocker therapy].
Topics: Adrenergic beta-Antagonists; Aged; Carteolol; Creatine Kinase; Female; Humans; Hypertension; Male; M | 1986 |
Effect of carteolol on renal function in healthy subjects and patients with hypertension.
Topics: Adult; Blood Pressure; Carteolol; Creatinine; Glomerular Filtration Rate; Glomerulonephritis; Humans | 1989 |
[Antihypertensive treatment with captopril or carteolol in elderly patients].
Topics: Aged; Blood Pressure; Captopril; Carteolol; Drug Evaluation; Female; Humans; Hypertension; Male; Mid | 1987 |
[Clinical significance of the ISA (intrinsic sympathomimetic activity) of the beta blocker carteolol].
Topics: Carteolol; Coronary Disease; Electrocardiography; Heart Rate; Humans; Hypertension; Propanolamines; | 1987 |
Carteolol treatment of essential hypertension: a long-term study of safety and efficacy.
Topics: Adult; Aged; Body Weight; Carteolol; Electrocardiography; Female; Humans; Hypertension; Male; Middle | 1986 |
Cough associated with the use of captopril.
Topics: Aged; Captopril; Carteolol; Cough; Drug Therapy, Combination; Female; Humans; Hypertension; Methyldo | 1985 |
Effects of long use of a beta-blocker, carteolol, on exercise hemodynamics in hypertensives.
Topics: Administration, Oral; Adult; Blood Pressure; Cardiac Output; Carteolol; Exercise Test; Female; Heart | 1985 |